<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="72217">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01946542</url>
  </required_header>
  <id_info>
    <org_study_id>Pro00047311</org_study_id>
    <nct_id>NCT01946542</nct_id>
  </id_info>
  <brief_title>Acute Effects of Beet Juice Consumption on Exercise Capacity in Heart Failure</brief_title>
  <official_title>Acute Effects of Beet Juice Consumption on Exercise Capacity in Heart Failure</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Jason Allen, Ph.D.</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Duke University</source>
  <oversight_info>
    <authority>United States: Food and Drug Administration</authority>
    <authority>United States: Institutional Review Board</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this project will be to determine whether consumption of beet juice
      concentrate prior to exercise may acutely improve exercise tolerance in patients with heart
      failure.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>February 2014</start_date>
  <completion_date type="Anticipated">December 2014</completion_date>
  <primary_completion_date type="Anticipated">October 2014</primary_completion_date>
  <phase>Phase 1/Phase 2</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Investigator, Outcomes Assessor), Primary Purpose: Supportive Care</study_design>
  <primary_outcome>
    <measure>exercise tolerance</measure>
    <time_frame>&lt; one day</time_frame>
    <safety_issue>No</safety_issue>
    <description>treadmill time to exhaustion, cardiopulmonary exercise test</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>vascular function</measure>
    <time_frame>&lt; one day</time_frame>
    <safety_issue>No</safety_issue>
    <description>flow-mediated dilation (FMD)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Heart Failure</condition>
  <arm_group>
    <arm_group_label>placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>placebo drink, single dose, taste and color-matched to experimental drink</description>
  </arm_group>
  <arm_group>
    <arm_group_label>beet juice concentrate</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>single dose of beet juice concentrate, roughly 70 mL</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>beet juice concentrate</intervention_name>
    <description>single dose of beet juice concentrate, roughly 70 mL</description>
    <arm_group_label>beet juice concentrate</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>placebo</intervention_name>
    <arm_group_label>placebo</arm_group_label>
    <other_name>placebo drink, single dose, taste and color-matched to experimental drink</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  New York Heart Association (NYHA) class II-III heart failure

          -  receiving optimal medical therapy

          -  sedentary

        Exclusion Criteria:

          -  smoking

          -  changes in medication or major cardiovascular (CV) event or procedure within the
             previous 6 wk

          -  fixed rate pacemaker

          -  unstable angina

          -  other co-morbidities or limitations that preclude safe participation in the exercise
             testing

          -  plans for hospitalization or cardiac transplantation within the next 2 months

          -  type 1 diabetes

          -  refusal or inability to provide informed consent
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>55 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>William Kraus, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Duke University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Leslie Kelly</last_name>
    <email>lsstudiesresearch@dm.duke.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>Duke University Medical Center</name>
      <address>
        <city>Durham</city>
        <state>North Carolina</state>
        <zip>27710</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>William E Kraus, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jason D Allen, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Kenjale AA, Ham KL, Stabler T, Robbins JL, Johnson JL, Vanbruggen M, Privette G, Yim E, Kraus WE, Allen JD. Dietary nitrate supplementation enhances exercise performance in peripheral arterial disease. J Appl Physiol (1985). 2011 Jun;110(6):1582-91. doi: 10.1152/japplphysiol.00071.2011. Epub 2011 Mar 31.</citation>
    <PMID>21454745</PMID>
  </reference>
  <verification_date>April 2014</verification_date>
  <lastchanged_date>April 16, 2014</lastchanged_date>
  <firstreceived_date>September 17, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Duke University Medical Center</investigator_affiliation>
    <investigator_full_name>Jason Allen, Ph.D.</investigator_full_name>
    <investigator_title>Assistant Professor of Medicine</investigator_title>
  </responsible_party>
  <keyword>exercise</keyword>
  <keyword>heart failure</keyword>
  <keyword>fatigue</keyword>
  <keyword>physical endurance</keyword>
  <keyword>functional food</keyword>
  <is_fda_regulated>Yes</is_fda_regulated>
  <is_section_801>Yes</is_section_801>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Heart Failure</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
